Cell

Cell is a peer-reviewed scientific journal publishing research papers across a broad range of disciplines within the life sciences. Areas covered include molecular biology, cell biology, systems biology, stem cells, developmental biology, genetics and genomics, proteomics, cancer research, immunology, neuroscience, structural biology, microbiology, virology, physiology, biophysics, and computational biology. The journal was established in 1974 by Benjamin Lewin and is published twice monthly by Cell Press, an imprint of Elsevier. Benjamin Lewin founded Cell in January 1974, under the aegis of MIT Press. He then bought the title and established an independent Cell Press in 1986. In April 1999, Lewin sold Cell Press to Elsevier. The "Article of the Future" feature was the recipient of a 2011 PROSE Award for Excellence in Biological & Life Sciences presented by the Professional and Scholarly Publishing Division of the Association of American Publishers. According to ScienceWatch, the journal was ranked first overall in the category of highest-impact journals (all fields) over 1995–2005 with an average of 161.2 citations per paper.

Publisher
Cell Press
History
1974–present
Impact factor
32.401 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Medical research

Preventing the onset of schizophrenia in a mouse model

Although predisposing processes occur earlier, schizophrenia emerges at young adulthood, suggesting it might involve a pathological transition during late brain development in predisposed individuals. Using a genetic mouse ...

Inflammatory disorders

Drug resistance signature discovered in Crohn's disease

By mapping out more than 100,000 immune cells in patients with Crohn's disease, Mount Sinai researchers have discovered a signature of cells that are involved in a type of the disease that does not respond to treatment, according ...

Oncology & Cancer

Genome screen uncovers new targets for cancer immunotherapy

Immunotherapy has revolutionized the treatment of cancer in the last decade, yet many tumors do not respond to these new therapies. A new genome-wide screen of 20,000 human genes in T cells have turned up several new candidates ...

page 1 from 30